Visual Abstract | Priority agenda to advance research in MDS: the first international workshop in MDS

The MDS Hub is pleased to present a visual abstract summarizing the top 10 priorities from the first international workshop in myelodysplastic syndromes (iwMDS), held in Florida, US, in June 2022.

Given the molecular, biological, and clinical heterogeneity of MDS, conducting translational research is challenging, and treatment often involves a complex variety of therapeutic approaches. During this first international workshop in MDS, participants concluded 10 critical needs for MDS globally and proposed specific measures to improve future research. Below, we summarize the proposed specific actions going forward from this meeting, followed by the top 10 research priorities these actions support (Table 1). These research priorities included making specific improvements to current treatment options, updating the criteria used for MDS, streamlining the differences between the International Consensus Classification and the 5th edition of the World Health Organization recommendations (previously covered by the MDS Hub), and enabling global collaborative data and clinical trials.